Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.

PLoS One · 2012 · PMC3278409 · PMID 22348002

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp-value<0.001actually significant

We saw similar, and highly significant differences for the published high-grade, late stage, serous tumors (HR = 1.3, 95%CI [1.1,1.6], logrank p-value<0.001) and the entire published ovarian dataset (HR = 1.4; 95%CI [1.2,1.6], logrank p-value<0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.